GROW Earnings

GROW reported its earnings on 2026-02-18, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a -1.88% price change on the earnings day and a 3.75% change over the next five days, reflecting market reactions to the results.

Following GROW's earnings announcement on 2026-02-18, the stock price moved by -1.88% on the day of the release. Over the subsequent five days, it saw a 3.75% change. Historically, GROW's stock price tends to shift by an average of -0.62% in the 10 days leading up to earnings and -0.01% in the 10 days following, providing insight into potential market.

For , analysts estimate GROW's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised upward by 30.92% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GROW's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised upward by 30.92%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GROW's stock price typically moves by -0.62% in the 10 days before its earnings and -0.01% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call summary presents a mixed outlook. Positive aspects include strong dividend and share repurchase programs, increased assets under management, and new product launches. However, risks such as high volatility in gold and oil markets, challenges in transitioning to ETFs, and a significant net loss due to tax adjustments offset these positives. The Q&A section lacks clarity, further adding uncertainty. Overall, the company's financial health and strategic initiatives are balanced by substantial risks, resulting in a neutral sentiment for stock price movement in the short term.